Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
7R01CA058492-04
Application #
2099174
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
1993-04-01
Project End
1997-05-31
Budget Start
1995-09-20
Budget End
1997-05-31
Support Year
4
Fiscal Year
1995
Total Cost
Indirect Cost
Name
University of Texas Medical Br Galveston
Department
Type
Organized Research Units
DUNS #
041367053
City
Galveston
State
TX
Country
United States
Zip Code
77555
Krause, D S; Mucenski, M L; Lawler, A M et al. (1998) CD34 expression by embryonic hematopoietic and endothelial cells does not require c-Myb. Exp Hematol 26:1086-92
Krause, D S; Kapadia, S U; Raj, N B et al. (1997) Regulation of CD34 expression in differentiating M1 cells. Exp Hematol 25:1051-61
Fackler, M J; Krause, D S; Smith, O M et al. (1995) Full-length but not truncated CD34 inhibits hematopoietic cell differentiation of M1 cells. Blood 85:3040-7
May, W S; Tyler, P G; Ito, T et al. (1994) Interleukin-3 and bryostatin-1 mediate hyperphosphorylation of BCL2 alpha in association with suppression of apoptosis. J Biol Chem 269:26865-70
Ito, T; Jagus, R; May, W S (1994) Interleukin 3 stimulates protein synthesis by regulating double-stranded RNA-dependent protein kinase. Proc Natl Acad Sci U S A 91:7455-9
Krause, D S; Ito, T; Fackler, M J et al. (1994) Characterization of murine CD34, a marker for hematopoietic progenitor and stem cells. Blood 84:691-701